New Results
Pathways analyses of schizophrenia GWAS focusing on known and novel drug targets
View ORCID ProfileH.A. Gaspar, View ORCID ProfileG. Breen
doi: https://doi.org/10.1101/091264
H.A. Gaspar
1King’s College London, Institute of Psychiatry, Psychology and Neuroscience, MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, UK
2National Institute for Health Research Biomedical Research Centre, South London and Maudsley National Health Service Trust, UK
G. Breen
1King’s College London, Institute of Psychiatry, Psychology and Neuroscience, MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, UK
2National Institute for Health Research Biomedical Research Centre, South London and Maudsley National Health Service Trust, UK
Article usage
Posted August 18, 2017.
Pathways analyses of schizophrenia GWAS focusing on known and novel drug targets
H.A. Gaspar, G. Breen
bioRxiv 091264; doi: https://doi.org/10.1101/091264
Subject Area
Subject Areas
- Biochemistry (13739)
- Bioengineering (10466)
- Bioinformatics (33251)
- Biophysics (17151)
- Cancer Biology (14217)
- Cell Biology (20168)
- Clinical Trials (138)
- Developmental Biology (10897)
- Ecology (16063)
- Epidemiology (2067)
- Evolutionary Biology (20382)
- Genetics (13430)
- Genomics (18674)
- Immunology (13796)
- Microbiology (32221)
- Molecular Biology (13406)
- Neuroscience (70225)
- Paleontology (528)
- Pathology (2200)
- Pharmacology and Toxicology (3748)
- Physiology (5892)
- Plant Biology (12040)
- Synthetic Biology (3373)
- Systems Biology (8182)
- Zoology (1846)